In the published article, two figures (1 and 2) were accidentally omitted but were subject to peer review and included in the original submission. The figures and respective citations have been added to the original article. Figure 1 has been cited at the end of 1 Introduction and Figure 2 has been cited at the end of the 6 Discussion. The missing figure and their captions appear below.
Figure 1
Figure 2
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Statements
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
perioperative period perioperative immunotherapy, neoadjuvant therapies, immunotherapy, neoadjuvant immune monotherapy, adjuvant therapy, biomarkers, NSCLC, lung cancer
Citation
Peng Y, Li Z, Fu Y, Pan Y, Zeng Y, Liu J, Xiao C, Zhang Y, Su Y, Li G and Wu F (2023) Corrigendum: Progress and perspectives of perioperative immunotherapy in non-small cell lung cancer. Front. Oncol. 13:1163376. doi: 10.3389/fonc.2023.1163376
Received
10 February 2023
Accepted
20 March 2023
Published
29 March 2023
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
13 - 2023
Updates
Copyright
© 2023 Peng, Li, Fu, Pan, Zeng, Liu, Xiao, Zhang, Su, Li and Wu.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Fang Wu, wufang4461@csu.edu.cn
†These authors have contributed equally to this work
This article was submitted to Cancer Immunity and Immunotherapy, a section of the journal Frontiers in Oncology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.